US drugmaker Indivior to pay $102.5 million to settle Suboxone monopoly claims
By Jonathan Stempel and Mariam Sunny (Reuters) -Indivior Plc said on Friday it agreed to pay $102.5 million to settle a lawsuit by dozens of U.S. states accusing it of illegally suppressing generic competition for its opioid addiction treatment Suboxone. The North Chesterfield, Virginia-based drugmaker denied wrongdoing in resolving claims by 41 U.S. states and …
US drugmaker Indivior to pay $102.5 million to settle Suboxone monopoly claims Read More »










